Cleared Traditional

K022516 - ELECSYS PROBNP IMMUNOASSAY (FDA 510(k) Clearance)

Nov 2002
Decision
112d
Days
Class 2
Risk

K022516 is an FDA 510(k) clearance for the ELECSYS PROBNP IMMUNOASSAY. This device is classified as a Test, Natriuretic Peptide (Class II - Special Controls, product code NBC).

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on November 19, 2002, 112 days after receiving the submission on July 30, 2002.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1117.

Submission Details

510(k) Number K022516 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 2002
Decision Date November 19, 2002
Days to Decision 112 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code NBC — Test, Natriuretic Peptide
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1117

Similar Devices — NBC Test, Natriuretic Peptide

All 8
Alere NT-proBNP for Alinity i
K253539 · Axis-Shield Diagnostics, Ltd. · Feb 2026
Alere NT-proBNP for Alinity i Reagent Kit
K241176 · Axis-Shield Diagnostics, Ltd. · Jan 2025
Access NT-proBNP
K232164 · Beckman Coulter, Inc. · Apr 2024
ADVIA Centaur® NT-proBNPII (PBNPII)
K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 2023
Elecsys proBNP II, Elecsys proBNP II STAT
K223637 · Roche Diagnostics · Jul 2023
Elecsys proBNP II, Elecsys proBNP II STAT
K210546 · Roche Diagnostics · Mar 2022